And finally, its high-profile China president, Leon Wang, has been detained by authorities over the past week. AstraZeneca has told investors that it does not have clear visibility on the reasons.

UK pharma major AstraZeneca, which has invested heavily in China, hosted a sell-side analyst call on Wednesday (November 6) to discuss the recent media reports about ongoing investigations in China.

(Alliance News) - AstraZeneca PLC said Thursday that the head of its China operations had been detained, after reports the firm was under investigation for potentially illegal data collection and drug ...

Leon Wang, executive vice president in charge of China and the broader Asian region, is being detained while the Chinese ...

China Has Detained a Senior AstraZeneca Executive Leon Wang, executive vice president in charge of China and the broader Asian region, is being detained while the Chinese government is probing ...

EU retail trade; U.K. BOE Rate decision; Germany Foreign trade, industrial production index; trading update from Rolls-Royce, Telefonica, Zurich Insurance Group, Pirelli & C, Veolia Environnement, ...

Pharmaceutical giant AstraZeneca said Thursday that the head of its China operations had been detained, after reports the ...

The Financial Times features significant stories in finance and business. AstraZeneca's China chief has been detained amid investigations, the UK regulator drops a probe into Unilever's "green" claims ...

Toyota’s July-September profit sank to less than half of what it was in the same period the previous year, as a production stoppage that followed a certification scandal and recalls dented vehicle ...

The company believes Chinese authorities are probing allegations that two current and two former employees had illegally ...

AstraZeneca stock tumbles as Chinese probe widens, implicating executives in insurance fraud and drug import violations ...